Ticker
CHRSCompany Name
COHERUS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt Paydown Yield | Market Capitalization | Net Cash Flow - Issuance (Repayment) of Debt Securities |
---|---|---|---|
6/30/2025 | 273.48% | $ 102.74M | $ -280.99M |
3/31/2025 | 158.07% | $ 118.25M | $ -186.92M |
12/31/2024 | 176.07% | $ 106.16M | $ -186.92M |
9/30/2024 | 224.09% | $ 83.41M | $ -186.92M |
6/30/2024 | 125.67% | $ 148.62M | $ -186.77M |
3/31/2024 | 0% | $ 243.22M | $ 0 |
12/31/2023 | 0% | $ 250.23M | $ 0 |
9/30/2023 | 0% | $ 394.23M | $ 0 |
6/30/2023 | -12.07% | $ 409.99M | $ 49.49M |
3/31/2023 | -7.55% | $ 655.71M | $ 49.49M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Debt) / Market Cap
(=) Debt Paydown Yield
Debt Paydown Yield for COHERUS ONCOLOGY INC is calculated as follows: (-1 * CF - Debt [ $ 203.99M ]) / Market Cap [ $ 1.32B ]
(=) Debt Paydown Yield [ -15.49% ]
Minimum
Mar 31, 2021
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.29K |
---|---|
min | -11.5% |
max | 11.52% |
average | -0.08% |
median | 0% |
std | 3.82% |